Home
Toolbox
Resource
Workflow
Tutorials
Citations
Downloads
Mutation Al-Predictor Flow
Gene-to-Mutation Flow
News & Insights
Genetic Encyclopedia
Frontiers
Industry Insights
Case Studies
About Us
About the Site
Contact Us
Private Policy
User Agreement
COL4A5 c.1390G>A
ALS1
DMD c.1332-11868C>G
TP53
肌萎缩侧索硬化症1型
USH2A c.8559-2A>G
囊性纤维化
Log In
|
Sign Up
中文
人类
AP3M1 - Adaptor Related Protein Complex 3 Subunit Mu 1
Create a favorites folder
Cancel
Confirm
Add To Favorites
Select a favorites
Description
New favorites >>
Cancel
Confirm
Favorite
Basic Information
Sequence Homology
Related Diseases and Mutations
Transcripts & Proteins
Gene Expression
Interactions
Related Mouse Models
Related Drugs
References Literature
这个基因编码的蛋白质是AP-3的中亚基,AP-3是一个与高尔基区域以及更外围的细胞内结构相关的适配器相关蛋白复合体。AP-3促进高尔基膜上的囊泡芽生,并可能直接在向内质网/溶酶体系统的蛋白质分类中发挥作用。AP-3是一个异四聚体蛋白质复合体,由两个大亚基(delta和beta3)、一个中亚基(mu3)和一个小亚基(sigma 3)组成。AP-3的一个大亚基的突变与Hermansky-Pudlak综合症有关,这是一种以缺陷性溶酶体相关细胞器为特征的遗传性疾病。这个基因的可变剪接导致多个转录变异体。[RefSeq,2016年2月提供]
Related ID:
NCBI:26985
ENSEMBL:ENSG00000185009
HGNC:569
UNIPROT:Q9Y2T2
OMIM:610366
Basic Information
NCBI
Transcripts
Exons
Length
MW (kDa)
Mutations
Related Diseases
Related Mouse Models
Reference
26985
7
9
30574 bp
46.94
16
--
4
6
AP3M1 Genetics information (-)
GRCh38
Sequence Homology
Related Diseases and Mutations
#
Disease
Anatomical Category
Score
Mutations
No data available
Transcripts & Proteins
Table View
Tile View
#
Transcript
Length(nt)
Exon Count
CDS(bp)
Protein
Length(aa)
No data available
* This data comes from NCBI.
Gene Expression
Tissue-specific RNA expression
Organ
Abundance
Alphabetical
Cell-specific RNA expression
Organ
Abundance
Alphabetical
Interactions
Reset
Acting
Regulation
Detail
Mechanism
Target
Residues
Reference
Score
No data available
Related Mouse Models
Type
Name
MGI
Strain of Origin
Publications
Mutations
No data available
Related Drugs
Name
CAS Number
Status
Phase
Link
No data available
References Literature
Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Mutation Direct
Sequence
Comparison
Al agent
Tutorials
Back to top